CD44 and non-small cell lung carcinoma: miR-125b, a miRNA known to promote M1 macrophage polarization, was delivered using CD44-targeted hyaluronic acid-poly(ethylenimine) (HA-PEI) NPs in a non-small cell lung cancer (NSCLC) model.